These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20361170)

  • 21. Understanding generics.
    Kircik LH
    J Drugs Dermatol; 2014 Jul; 13(7):s75-6. PubMed ID: 25007375
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug discovery favors simple observation of the prepared mind.
    Dinulos JG
    Curr Opin Pediatr; 2013 Aug; 25(4):471-3. PubMed ID: 23695718
    [No Abstract]   [Full Text] [Related]  

  • 23. [Etretinate (Tigason). A drug for skin diseases with disturbances in keratinization].
    Langeland J; Mørk NJ
    Tidsskr Nor Laegeforen; 1982 Oct; 102(30):1579-80. PubMed ID: 6188237
    [No Abstract]   [Full Text] [Related]  

  • 24. Glucocorticoid and sex hormone receptors: clinical implications and therapeutic relevance.
    Stefanaki C; Chrousos GP; Katsambas A
    Dermatol Clin; 2007 Oct; 25(4):503-13, viii. PubMed ID: 17903609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What's new in dermatologic therapy.
    Thiers BH
    Dermatol Ther; 2008; 21(2):142-9. PubMed ID: 18394088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Proposals on simplification of dermatological dispensing].
    Flegel H
    Dermatol Wochenschr; 1966 Jan; 152(1):16-20. PubMed ID: 5973530
    [No Abstract]   [Full Text] [Related]  

  • 27. Choosing dermatologic therapies.
    Wilkin J
    Dermatol Ther; 2009; 22(3):187-90. PubMed ID: 19453341
    [No Abstract]   [Full Text] [Related]  

  • 28. Dermatologic medication adherence.
    Nolan BV; Feldman SR
    Dermatol Clin; 2009 Apr; 27(2):113-20, v. PubMed ID: 19254654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uses and complications of isotretinoin therapy.
    Ellis CN; Krach KJ
    J Am Acad Dermatol; 2001 Nov; 45(5):S150-7. PubMed ID: 11606947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate: role of treatment in skin disease.
    Holliday AC; Moody MN; Berlingeri-Ramos A
    Skin Therapy Lett; 2013; 18(3):4-9. PubMed ID: 23674145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic effectiveness of propolene in certain skin and fungal diseases].
    Mordovtsev VN; Rukavishnikova VM
    Vestn Dermatol Venerol; 1973 Feb; 47(2):69-72. PubMed ID: 4756592
    [No Abstract]   [Full Text] [Related]  

  • 32. [External agents for the care and treatment of the skin].
    Fröhlich HH
    Pharm Unserer Zeit; 1979 Nov; 8(6):179-88. PubMed ID: 538049
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug treatments for skin disease introduced in 2010.
    Skin Therapy Lett; 2011 Feb; 16(2):6-8. PubMed ID: 21591545
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pimecrolimus (SDZ ASM 981). Current state of research].
    Dissemond J; Goos M; Wagner SN
    Dtsch Med Wochenschr; 2002 May; 127(22):1199-203. PubMed ID: 12035117
    [No Abstract]   [Full Text] [Related]  

  • 35. Moisturizers: adjunct therapy and advising patients.
    Jackson EM
    Am J Contact Dermat; 1996 Dec; 7(4):247-50. PubMed ID: 8955489
    [No Abstract]   [Full Text] [Related]  

  • 36. Moisturizing the skin.
    Heald P; Burton CS; Callaway JL
    N C Med J; 1983 Apr; 44(4):234. PubMed ID: 6574335
    [No Abstract]   [Full Text] [Related]  

  • 37. [Daily dermatologic therapy].
    Tchou PK
    Laval Med; 1970 Sep; 41(7):951-4. PubMed ID: 4396423
    [No Abstract]   [Full Text] [Related]  

  • 38. Antihelmintic and antiparasitic drugs: unapproved uses or indications.
    Goihman-Yahr M
    Clin Dermatol; 2000; 18(1):113-7. PubMed ID: 10701092
    [No Abstract]   [Full Text] [Related]  

  • 39. Updates & perspectives on management of common dermatologic disorders.
    Del Rosso JQ
    J Drugs Dermatol; 2007 Jun; 6(6):662-4. PubMed ID: 17668533
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative efficacy of topical antipsoriatic treatments, systemic treatment and biologics: is severity assessment beyond Psoriasis Area and Severity Index a necessity?
    van de Kerkhof PC; Mrowietz U; Segaert S; Kragballe K
    Br J Dermatol; 2007 Apr; 156(4):771-2. PubMed ID: 17263798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.